- Home
- SPPP vs DERM Comparison
SPPP vs DERM Comparison
Compare SPPP & DERM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SPPP
- DERM
- Stock Information
- Founded
- SPPP 2011
- DERM 2014
- Country
- SPPP Canada
- DERM United States
- Employees
- SPPP N/A
- DERM N/A
- Industry
- SPPP
- DERM Biotechnology: Pharmaceutical Preparations
- Sector
- SPPP
- DERM Health Care
- Exchange
- SPPP NYSE
- DERM Nasdaq
- Market Cap
- SPPP 172.2M
- DERM 181.0M
- IPO Year
- SPPP N/A
- DERM 2021
- Fundamental
- Price
- SPPP $11.28
- DERM $6.28
- Analyst Decision
- SPPP
- DERM Strong Buy
- Analyst Count
- SPPP 0
- DERM 2
- Target Price
- SPPP N/A
- DERM $10.00
- AVG Volume (30 Days)
- SPPP 183.3K
- DERM 97.5K
- Earning Date
- SPPP 01-01-0001
- DERM 08-11-2025
- Dividend Yield
- SPPP N/A
- DERM N/A
- EPS Growth
- SPPP N/A
- DERM N/A
- EPS
- SPPP N/A
- DERM N/A
- Revenue
- SPPP N/A
- DERM $56,243,000.00
- Revenue This Year
- SPPP N/A
- DERM $28.99
- Revenue Next Year
- SPPP N/A
- DERM $52.61
- P/E Ratio
- SPPP N/A
- DERM N/A
- Revenue Growth
- SPPP N/A
- DERM N/A
- 52 Week Low
- SPPP $8.55
- DERM $3.54
- 52 Week High
- SPPP $11.39
- DERM $8.25
- Technical
- Relative Strength Index (RSI)
- SPPP 61.09
- DERM 38.72
- Support Level
- SPPP $11.24
- DERM $6.29
- Resistance Level
- SPPP $11.58
- DERM $7.13
- Average True Range (ATR)
- SPPP 0.23
- DERM 0.41
- MACD
- SPPP 0.01
- DERM -0.15
- Stochastic Oscillator
- SPPP 59.32
- DERM 3.31
About SPPP SPROTT PHYS PLATINUM & PALLADIUM
Sprott Physical Platinum & Palladium Tr invests and holds all of its assets in physical platinum and palladium bullion. The company seeks to provide a secure, convenient, and exchange-traded investment alternative for investors interested in holding physical platinum and palladium bullion without the inconvenience that is typical of a direct investment in physical bullion. The Trust invests mainly in long-term holdings of unencumbered, fully allocated, physical platinum and palladium bullion.
About DERM Journey Medical Corporation
Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's current product portfolio includes eight FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.